Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 01/12/08 |
Steven Quay
CEO | Chief Executive Officer | 73 | 01/12/08 |
Heather Rees
DFI | Director of Finance/CFO | 51 | 01/01/17 |
Arezoo Mirad
CTO | Chief Tech/Sci/R&D Officer | - | 04/12 |
Richard Graydon
CTO | Chief Tech/Sci/R&D Officer | - | 25/10/22 |
Delly Behen
ADM | Chief Administrative Officer | - | 01/01/14 |
Eric van Zanten
IRC | Investor Relations Contact | - | 07/12/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 01/12/08 |
Director/Board Member | 66 | 01/03/14 | |
H. Remmel
BRD | Director/Board Member | 72 | 01/02/12 |
Shu-Chih Chen
FOU | Founder | 62 | 01/12/08 |
Stephen Galli
BRD | Director/Board Member | 77 | 01/07/11 |
Jonathan Finn
BRD | Director/Board Member | 50 | 08/11 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 127 077 462 | 125 684 004 ( 98,90 %) | 1 320 046 ( 1,039 %) | 98,90 % |
Azione B | 0 | 582 | 0 | 0 |
Coordinate società
Atossa Therapeutics, Inc.
107 Spring Street
98104, Seattle
+206 588 0256
http://www.atossatherapeutics.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+17,09% | 45,34 Mrd | |
+42,10% | 40,42 Mrd | |
-9,70% | 37,92 Mrd | |
+33,28% | 31,75 Mrd | |
-8,98% | 27,71 Mrd | |
+13,37% | 26,52 Mrd | |
+44,11% | 13,96 Mrd | |
+32,33% | 12,44 Mrd | |
-7,26% | 11,26 Mrd |